Clinical prognostic factors within the high volume subgroup of metastatic hormone sensitive prostate cancer (mHSPC) in ENZAMET (ANZUP 1304)

Simple item page
dc.contributor.authorHamid, A.A.
dc.contributor.authorThomas, H.
dc.contributor.authorMartin, A.
dc.contributor.authorSoon, Y.Y.
dc.contributor.authorHorvath, L.G.
dc.contributor.authorZielinski, R.
dc.contributor.authorThomson, A.
dc.contributor.authorTan, H.
dc.contributor.authorSandhu, S.K.
dc.contributor.authorReaume, M.N.
dc.contributor.authorPook, D.W.
dc.contributor.authorParnis, F.
dc.contributor.authorMcDermott, R.S.
dc.contributor.authorLawrence, N.
dc.contributor.authorFrydenberg, M.
dc.contributor.authorChi, K.N.
dc.contributor.authorStockler, M.R.
dc.contributor.authorDavis, I.D.
dc.contributor.authorSweeney, C.
dc.contributor.conferenceEuropean Society for Medical Oncology Congress (ESMO) (13 Sep 2024 - 17 Sep 2024 : Barcelona, Spain)
dc.date.issued2024
dc.descriptionAbstract #1618P
dc.description.statementofresponsibilityA.A. Hamid, H. Thomas, A. Martin, Y.Y. Soon, L.G. Horvath, R. Zielinski, A. Thomson, H. Tan, S.K. Sandhu, M.N. Reaume, D.W. Pook, F. Parnis, R.S. McDermott, N. Lawrence, M. Frydenberg, K.N. Chi, M.R. Stockler, I.D. Davis, C. Sweeney
dc.identifier.citationAbstracts of the European Society for Medical Oncology Congress (ESMO 2024), as published in Annals of Oncology, 2024, vol.35, iss.Suppl. 2, pp.S977-S978
dc.identifier.doi10.1016/j.annonc.2024.08.1699
dc.identifier.issn0923-7534
dc.identifier.issn1569-8041
dc.identifier.urihttps://hdl.handle.net/2440/148019
dc.language.isoen
dc.publisherElsevier
dc.relation.grantNHMRC
dc.rights© 2024 Published by Elsevier Ltd.
dc.source.urihttps://www.annalsofoncology.org/issue/S0923-7534(24)X0010-1
dc.titleClinical prognostic factors within the high volume subgroup of metastatic hormone sensitive prostate cancer (mHSPC) in ENZAMET (ANZUP 1304)
dc.typeConference item
pubs.publication-statusPublished

Files

Collections

Research Outputs